ACHV
Achieve Life Sciences (ACHV)
$10
About Achieve Life Sciences (ACHV)
Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
Details
Daily high
$5.43
Daily low
$4.94
Price at open
$4.94
52 Week High
$6.16
52 Week Low
$2.00
Market cap
497.9M
Dividend yield
0.00%
Volume
2.9M
Avg. volume
1.7M
P/E ratio
-4.35
Achieve Life Sciences News
Details
Daily high
$5.43
Daily low
$4.94
Price at open
$4.94
52 Week High
$6.16
52 Week Low
$2.00
Market cap
497.9M
Dividend yield
0.00%
Volume
2.9M
Avg. volume
1.7M
P/E ratio
-4.35